Your browser doesn't support javascript.
loading
MDM2 antagonist nutlin-3a sensitizes tumors to V-ATPase inhibition.
Schneider, Lina S; Ulrich, Melanie; Lehr, Thorsten; Menche, Dirk; Müller, Rolf; von Schwarzenberg, Karin.
Afiliação
  • Schneider LS; Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University of Munich, Butenandtstrasse 5-13, 81377 Munich, Germany.
  • Ulrich M; Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University of Munich, Butenandtstrasse 5-13, 81377 Munich, Germany.
  • Lehr T; Clinical Pharmacy, Saarland University, Campus C2 2, 66123 Saarbrücken, Germany.
  • Menche D; Kekulé Institute of Organic Chemistry and Biochemistry, University of Bonn, Gerhard-Domagk-Str. 1, 53121 Bonn, Germany.
  • Müller R; Saarland University, Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, PO 151150, 66042 Saarbrücken, Germany.
  • von Schwarzenberg K; Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University of Munich, Butenandtstrasse 5-13, 81377 Munich, Germany. Electronic address: karin.von.schwarzenberg@cup.uni-muenchen.de.
Mol Oncol ; 10(7): 1054-62, 2016 08.
Article em En | MEDLINE | ID: mdl-27157929

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Adenosina Trifosfatases / Proteínas Proto-Oncogênicas c-mdm2 / Imidazóis / Neoplasias Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Adenosina Trifosfatases / Proteínas Proto-Oncogênicas c-mdm2 / Imidazóis / Neoplasias Idioma: En Ano de publicação: 2016 Tipo de documento: Article